We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RST
11751
CALL
DELISTED
ROSETTA STONE INC
RST
-17,700
Closed -$531K
RST
11752
PUT
DELISTED
ROSETTA STONE INC
RST
-14,500
Closed -$435K
AIMT
11753
CALL
DELISTED
Aimmune Therapeutics
AIMT
-63,000
Closed -$2.17M
AIMT
11754
DELISTED
Aimmune Therapeutics
AIMT
-75,551
Closed -$2.6M
AIMT
11755
PUT
DELISTED
Aimmune Therapeutics
AIMT
-16,600
Closed -$572K
ONDK
11756
CALL
DELISTED
On Deck Capital, Inc.
ONDK
-15,600
Closed -$25K
ONDK
11757
DELISTED
On Deck Capital, Inc.
ONDK
-12,451
Closed -$20K
AKCA
11758
DELISTED
Akcea Therapeutics Inc
AKCA
-25,890
Closed -$470K
MNK
11759
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-448,900
Closed -$437K
MNK
11760
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-32,085
Closed -$31K
MNK
11761
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-153,300
Closed -$149K
LONE
11762
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
-247,330
Closed -$57K
VSLR
11763
CALL
DELISTED
VIVINT SOLAR, INC.
VSLR
-121,000
Closed -$5.12M
VSLR
11764
DELISTED
VIVINT SOLAR, INC.
VSLR
-284,645
Closed -$12.1M
VSLR
11765
PUT
DELISTED
VIVINT SOLAR, INC.
VSLR
-98,700
Closed -$4.18M
AMTD
11766
CALL
DELISTED
TD Ameritrade Holding Corp
AMTD
-32,500
Closed -$1.27M
AMTD
11767
DELISTED
TD Ameritrade Holding Corp
AMTD
-30,208
Closed -$1.18M
AMTD
11768
PUT
DELISTED
TD Ameritrade Holding Corp
AMTD
-52,200
Closed -$2.04M
NBL
11769
CALL
DELISTED
Noble Energy, Inc.
NBL
-116,900
Closed -$999K
NBL
11770
DELISTED
Noble Energy, Inc.
NBL
-14,453,773
Closed -$124M
NBL
11771
PUT
DELISTED
Noble Energy, Inc.
NBL
-136,700
Closed -$1.17M
ETFC
11772
CALL
DELISTED
E*Trade Financial Corporation
ETFC
-106,200
Closed -$5.32M
ETFC
11773
DELISTED
E*Trade Financial Corporation
ETFC
-15,104
Closed -$756K
ETFC
11774
PUT
DELISTED
E*Trade Financial Corporation
ETFC
-93,200
Closed -$4.67M
PFNX
11775
DELISTED
Pfenex Inc.
PFNX
-23,562
Closed -$300K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.